Page last updated: 2024-08-17

uridine triphosphate and losartan

uridine triphosphate has been researched along with losartan in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brailoiu, E; de Zeeuw, D; Deelman, LE; Filipeanu, CM; Henning, RH; Nelemans, SA1
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Taguchi, K1

Other Studies

2 other study(ies) available for uridine triphosphate and losartan

ArticleYear
Intracellular angiotensin II inhibits heterologous receptor stimulated Ca2+ entry.
    Life sciences, 2001, Nov-30, Volume: 70, Issue:2

    Topics: Angiotensin II; Animals; Calcium; Cell Line; Imidazoles; Liposomes; Losartan; Muscle, Smooth; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Serotonin; Uridine Triphosphate

2001
Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:5

    Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dinoprost; Dinoprostone; Disease Models, Animal; Group IV Phospholipases A2; Losartan; Male; Membrane Proteins; Mesenteric Artery, Superior; Phosphorylation; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Signal Transduction; Superoxides; Uridine Triphosphate; Vasoconstriction

2011